Children with Down syndrome have a significantly increased risk of leukemia, while adults have a lower risk of several common ...
Scientists have achieved a genetic feat once thought impossible: removing an entire extra human chromosome using gene-editing ...
New microbiome data show that intestinal bacteria can generate clinically relevant alcohol levels, validating a rare syndrome ...
In late January and early February 2026, Ultragenyx Pharmaceutical announced positive long-term clinical data for UX111, its ...
Frank Wu was born in Cleveland, Ohio. But when certain people ask him, “Where are you from?” they’ll follow his answer with, ...
By Dr. Sanchari Sinha Dutta, Ph.D. Three days of oat-heavy meals spark gut-derived phenolic metabolites linked to rapid ...
Regenxbio Inc. faces pivotal catalysts in 2026, notably RGX-121's FDA decision and RGX-202 Duchenne data, potentially ...
Dizziness stemming from viral infections presents a complex diagnostic landscape. While Vestibular Neuritis (VN) and Ramsay Hunt Syndrome (RHS) with ...
Patients will be able to find out whether they have genes linked to cancer using a world-leading tool developed by the NHS.
Targeted therapies, including BTK inhibitors and venetoclax, have replaced chemoimmunotherapy as the first-line standard for CLL, emphasizing patient preference and risk factors in treatment decisions ...
A first clinical study suggests allogeneic CD19-targeted CAR-T cell therapy can safely induce durable remission in patients with severe, treatment-refractory systemic lupus erythematosus.